Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China · Delayed Price · Currency is CNY 12.37
-0.09 (-0.72%)
Jun 17, 2026, 11:30 AM CST
SHA:600161 Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, SHA:600161 stock has a consensus rating of "Buy" and an average price target of ¥19.50. The average 1-year stock price forecast is 57.64% higher than the current stock price, while the lowest is ¥15.00 (+21.26%) and the highest is ¥24.00 (+94.02%).
Price Target: ¥19.50 (+57.64%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHA:600161 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 1 | 1 |
| Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 7 | 6 | 4 | 4 |
Financial Forecast
Revenue This Year
6.34B
from 6.17B
Increased by 2.72%
Revenue Next Year
7.11B
from 6.34B
Increased by 12.29%
EPS This Year
0.58
from 0.54
Increased by 7.73%
EPS Next Year
0.67
from 0.58
Increased by 15.15%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.9B | ||
| Avg | 6.3B | ||
| Low | 5.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.4% | ||
| Avg | 2.7% | ||
| Low | -6.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.58 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 7.7% | ||
| Low | - |